Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the development, production, and commercialization of insulin analogs and medical devices in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The company also offers GanleePen, an insulin injection device; and GanleeFine, an insulin pen needle. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Frequently asked questions
What sector does Gan & Lee Pharmaceuticals Co Ltd (603087) operate in?
Gan & Lee Pharmaceuticals Co Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) current stock price?
As of the latest data, Gan & Lee Pharmaceuticals Co Ltd stock price is CN¥72.00, with a previous close of CN¥67.00. Gan & Lee Pharmaceuticals Co Ltd gained CN¥5.00 in the last trading session, representing a 7.46% increase.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) current market capitalization?
Gan & Lee Pharmaceuticals Co Ltd market cap is approximately 43.05 billion.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.94, and the forward EPS is CN¥2.73.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) Price-to-Earnings (P/E) ratio?
Gan & Lee Pharmaceuticals Co Ltd current P/E ratio is 37.11, with a forward P/E of 26.34.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) EBITDA?
Gan & Lee Pharmaceuticals Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 495.53 million.
Does Gan & Lee Pharmaceuticals Co Ltd (603087) pay dividends?
No. Gan & Lee Pharmaceuticals Co Ltd does not pay a dividend.
How did Gan & Lee Pharmaceuticals Co Ltd (603087) perform in its most recent earnings report?
In the last report (June 30, 2026), Gan & Lee Pharmaceuticals Co Ltd posted an EPS surprise of -9.09% and a revenue surprise of 2.8%.
What is Gan & Lee Pharmaceuticals Co Ltd (603087) beta (volatility) score?
Gan & Lee Pharmaceuticals Co Ltd has a beta of 0.261, indicating lower volatility than the overall market.
